Teva Pharmaceutical says it has gained a green light in the USA to market its copycat version of Procter & Gamble’s $1 billion a year osteoporosis drug Actonel (risedronate) in three different doses, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results